Suresh S. Ramalingam, MD, FACP, FASCO, discusses the exploration of patritumab deruxtecan in non–small cell lung cancer.
Suresh Ramalingam, MD, Winship Cancer Institute Emory University
Advertisement
Articles by Suresh Ramalingam, MD, Winship Cancer Institute Emory University
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer
3
Bispecific-Based Approaches Highlight Key Multiple Myeloma Data Set to Emerge at EHA 2026
4
Dato-DXd Hits Key Secondary Efficacy End Points in First-Line TNBC
5